Ready or Not: Responding to Measles in the Postelimination Era
Authors: Julia Shaklee Sammons
Journal: Annals of Internal Medicine (2014)

Ideas and Opinions15 July 2014Ready or Not: Responding to Measles in the Postelimination EraFREEJulia Shaklee Sammons, MD, MSCEJulia Shaklee Sammons, MD, MSCEFrom Perelman School of Medicine, University of Pennsylvania, and Division of Infectious Diseases and Department of Infection Prevention and Control, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M14-0892 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Although endemic measles was eliminated in the United States in 2000 (1), 2 concurrent measles outbreaks at opposite ends of the country offer a sobering reminder of the threat of this global disease. As more parents decline to vaccinate their children, measles incidence is increasing—a fact that alarms me both as a hospital epidemiologist and as a parent of a vulnerable infant too young to receive the measles vaccine. Because infected patients are likely to seek medical care, hospitals and clinics may inadvertently fuel transmission if patients with measles are not rapidly triaged and isolated. Yet, because of the success of the measles vaccine, many clinicians have never seen measles and may not be able to recognize its features. It is crucial that providers become familiar with this deadly disease and apply the necessary control measures to contain it.An estimated 20 million cases of measles occur each year worldwide (2). In the prevaccine era, approximately 500 000 measles cases occurred in the United States annually, with 500 deaths and 48 000 hospitalizations (1). After elimination, the median annual number of cases decreased to 60, but this number is steadily increasing. Since 2010, there has been an average of 155 cases per year (2, 3). In 2014, there has been 106 measles cases reported in the first 3 months alone (3).High vaccination coverage is essential to prevent spread after importation. However, coverage with measles, mumps, and rubella (MMR) vaccine varies by state. The recent outbreaks in New York City and Orange County, California, remind us how quickly imported cases of measles can spread in communities with large numbers of unvaccinated persons. Although vaccination coverage among children aged 19 to 35 months continues to be near or above 90% nationwide, 15 states had MMR vaccination rates below 90% according to the National Immunization Survey (4). States allowing philosophical exemptions from vaccination have significantly higher rates of unvaccinated children (5). In addition, unvaccinated children are likely to cluster geographically, thus increasing the risk for outbreaks after importation (5). In fact, most postelimination measles cases have been due to outbreaks. In 2013, 75% of cases in the first 8 months of the year were due to 8 outbreaks (2). Most occurred in unvaccinated persons (82%) or those with unknown vaccination status (9%) (2). As expected, 99% of cases could be linked to an imported case that led to a community-based outbreak. Of the imported measles cases, 50% were from Europe (2).Measles is one of the most contagious infectious diseases known, with secondary attack rates greater than 90% in susceptible contacts (6). Transmission occurs primarily through direct contact with infectious droplets; however, measles virus can survive for up to 2 hours in fine particle aerosols and be transmitted via inhalation of small droplets even without face-to-face contact (6). The incubation period ranges from 7 to 21 days but is generally 8 to 12 days from exposure to symptom onset. Persons with measles are contagious from 4 days before to 4 days after appearance of rash, underscoring the importance of early recognition for returned travelers with relevant symptoms even before the rash appears (7).It is essential that providers maintain a high level of suspicion for measles in persons with febrile rash illness who have recently traveled or have had contact with travelers and are able to recognize its clinical features (8). Measles is characterized by a prodrome of fever (up to 40.6 °C), cough, coryza, and conjunctivitis. A characteristic red, blotchy, “morbilliform” rash appears 2 to 4 days after symptom onset (Figure 1); it typically begins on the face before spreading downward and becoming confluent (8). Pathognomonic Koplik spots appear 1 to 2 days before the rash and last 2 to 3 days; they are small, slightly raised, bluish-white spots on an erythematous base and have been reported in 60% to 70% of patients with measles, although they are probably present in all cases (Figure 2) (7, 9). Measles rash may be confused with other viral exanthems (erythema infectiosum [fifth disease] or roseola), Kawasaki disease, or scarlet fever. Immunocompromised patients may not develop a characteristic rash (7). Complications are common in young children and include diarrhea, otitis media, bronchopneumonia, and croup; acute encephalitis occurs in 1 per 1000 cases and can lead to permanent brain damage. Death occurs in 1 to 3 per 1000 reported cases and is most common in young children or immunocompromised patients (1).Figure 1. Measles rash.Photograph from the Centers for Disease Control and Prevention Public Health Image Library, 1963 (ID 1150). Download figure Download PowerPoint Figure 2. Pathognomonic Koplik spots.Photograph courtesy of Dr. Jerome O. Klein. Download figure Download PowerPoint For suspected cases of measles, early reporting and rapid control efforts are vital to prevent spread in health care facilities. Providers should encourage patients and their parents to call before coming into medical offices or emergency departments so that appropriate precautions can be taken. Prompt consultation with the facility's infection control department is advisable, not only to provide real-time advice on appropriate control measures but also to assist with contact tracing and exposure management if needed. Laboratory confirmation should be sought through serologic testing or isolation of measles virus or identification of measles RNA from a clinical specimen (7). All cases should be reported promptly to the local health department.If measles is suspected, airborne precautions should be implemented immediately (8). Such precautions include appropriate patient isolation and the use of personal protective equipment. Patients with suspected measles should be isolated in a negative-air-pressure isolation room, or airborne-infection isolation room. These rooms are equipped with special air handling and ventilation systems that contain and safely remove infectious particles (10). Once the patient is appropriately isolated, providers should wear respiratory protection according to their facility's policies. Because current guidelines do not include specific guidance on respiratory protection (surgical mask vs. particulate respirator) (10), the practices of individual facilities may vary. If an airborne infection isolation room is unavailable, the patient should be placed in a private room with the door closed (10). A surgical mask can be worn by the patient to limit spread. If an examination room is not immediately available and the patient must remain in a waiting room, use of a surgical mask and distancing the patient from others may reduce the potential for exposures (10). Airborne precautions should be continued for 4 days after rash onset in healthy persons or for the duration of illness in immunocompromised patients; for those not requiring hospitalization, voluntary quarantine is advised.As measles incidence increases, clinicians have a vital role to play. We need to talk to our patients about measles vaccination and remind them what is at stake if imported measles cases continue to land in communities of unvaccinated persons, especially for those who are too young or ineligible to be vaccinated. Meanwhile, we must ensure that our facilities do not become centers for secondary measles transmission—prompt recognition of suspected cases and rapid implementation of control measures are critical to prevent further spread.References1. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62 RR-04 1-34. [PMID: 23760231] MedlineGoogle Scholar2. Centers for Disease Control and Prevention (CDC). Measles—United States, January 1–August 24, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:741-3. [PMID: 24025755] MedlineGoogle Scholar3. Centers for Disease Control and Prevention (CDC). Notifiable diseases and mortality tables. MMWR Morb Mortal Wkly Rep. 2014;63:277-300. MedlineGoogle Scholar4. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among children aged 19-35 months—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:733-40. [PMID: 24025754] MedlineGoogle Scholar5. Smith PJ, Chu SY, Barker LE. Children who have received no vaccines: who are they and where do they live? Pediatrics. 2004;114:187-95. [PMID: 15231927] CrossrefMedlineGoogle Scholar6. Centers for Disease Control and Prevention (CDC). Epidemiology and Prevention of Vaccine-Preventable Diseases: The Pink Book. 12th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2012. Google Scholar7. Pickering L. Red Book: The Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Acad Pediatrics; 2012. Google Scholar8. Kutty P, Rota J, Bellini W, Redd SB, Barskey A, Wallace G. Manual for the Surveillance of Vaccine-Preventable Diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2013. Google Scholar9. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189 Suppl 1 S4-16. [PMID: 15106083] CrossrefMedlineGoogle Scholar10. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35:S65-164. [PMID: 18068815] CrossrefMedlineGoogle Scholar Comments 0 Comments Sign In to Submit A Comment Julia Shaklee Sammons, MD, MSCEChildren's Hospital of Philadelphia9 September 2014 Author's Response I appreciate Dr. Duchin’s expansion on some of the nuances in measles recognition. It is true that clinical presentations may vary for those who have been previously vaccinated. Immunocompromised patients may also present with a modified clinical picture. In addition, I agree that the absence of Koplik spots should not exclude measles from the differential diagnosis of a patient who has other relevant clinical features and appropriate exposure history, particularly since the presence of Koplik spots is transient (2-3 days). Still, for providers who have never seen measles, the critical first step is awareness and the consideration of measles in returned travelers with febrile rash illness. The importance of appropriate isolation and use of airborne precautions for suspected and confirmed cases of measles cannot be overemphasized. Dr. Duchin appropriately points out recent guidance from the Advisory Committee on Immunization Practices (ACIP)1 that includes a recommendation for use of an N-95 respirator or respirator with similar effectiveness in preventing airborne transmission, which will hopefully be incorporated in an updated version of current guidelines for isolation precautions.2 References1. Shefer A, et al. Immunization of Health-Care Personnel. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR; November 25, 2011 /60(RR07);1-45 http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm.).2. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control 2007;35:S65-164. Jeffrey S. Duchin MDPublic Health - Seattle & King County and the University of Washington, Seattle24 July 2014 Responding to Measles in the Postelimination Era TO THE EDITOR: Sammons provides a timely reminder of the importance of measles case recognition and management given ongoing outbreaks of measles internationally and repeated introductions of infectious measles cases into the US triggering outbreaks1. Several additional points deserve mention. Although as Sammons rightly points out that it is critical for clinicians to be able to promptly recognize classical clinical cases of measles based on symptoms, signs, and the travel and exposure history. It is also important to note that among persons with pre-existing immunity including previously vaccinated persons (particularly among health care workers) and in persons from measles endemic countries that have had prior measles infection, re-exposure to measles can lead to a modified clinical illness that may not be initially recognized as measles2. Obtaining specimens for measles RNA testing is especially important in these cases as interpretation of serological tests can be difficult. Sammons also states that airborne precautions should be used for hospitalized measles cases, but that current guidelines do not specify whether a surgical mask or particulate respirator is indicted. Although the current (2007) guidance from the Healthcare Infection Control Practices Advisory Committee (HICPAC; Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee, 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf) is agnostic on this point, more recent guidance from the Centers for Disease Control and Prevention are clear that irrespective of vaccination history, HCW entering the room of suspected and confirmed measles cases are recommended to use an N95 or similarly protective respirator 3. Assuring and documenting that all HCW have had two doses of MMR minimizes the risk of infection and facilitates efficient management of HCW exposed to measles cases. And finally, in my experience, disproportionate significance is placed on the finding of Koplik spots in the assessment of potential measles cases. A report of Kpolik spots is understandably not very reliable given the general lack of familiarity of most practicing physicians with acute measles cases. More troubling is the tendency to erroneously interpret the absence of the pathognomic spots as evidence against acute measles infection. Jeffrey S. Duchin, MD Public Health - Seattle and King County and the University of Washington Seattle, Washington 1 Sammons JS. Ann Int Med. 2014;161:145-146 2 Rota JS, et al. J Infect Dis. (2011) 204 (suppl 1): S559-S563 doi:10.1093/infdis/jir098 3 Shefer A, et al. Immunization of Health-Care Personnel. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR; November 25, 2011 /60(RR07);1-45 http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm.). Author, Article, and Disclosure InformationAuthors: Julia Shaklee Sammons, MD, MSCEAffiliations: From Perelman School of Medicine, University of Pennsylvania, and Division of Infectious Diseases and Department of Infection Prevention and Control, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-0892.Corresponding Author: Julia Shaklee Sammons, MD, MSCE, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Main Building, A-Level, Room AE22, Philadelphia, PA 19104; e-mail, sammonsj@email.chop.edu.Author Contributions: Conception and design: J.S. Sammons.Analysis and interpretation of the data: J.S. Sammons.Drafting of the article: J.S. Sammons.Final approval of the article: J.S. Sammons.Collection and assembly of data: J.S. Sammons.This article was published online first at www.annals.org on 29 April 2014. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoResponding to Measles in the Postelimination Era Jeffrey S. Duchin Responding to Measles in the Postelimination Era Julia Shaklee Sammons Metrics Cited byCommon Childhood Viral InfectionsResponding to Measles in the Postelimination EraJeffrey S. Duchin, MDJournal Roundup 15 July 2014Volume 161, Issue 2 Page: 145-146 Keywords Children Hospitalizations Infectious diseases Kawasaki disease Measles MMR vaccine Rashes Vaccines Ventilators Viral diseases ePublished: 15 July 2014 Issue Published: 15 July 2014 Copyright & PermissionsCopyright © 2014 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...